Blood Test to Detect Early-Stage Lung Cancer Inches Closer to Reality
...
Already a member? Log in here
AMP Survey Finds that Inadequate Reimbursement Hinders Use of Molecular Diagnostics
...
Already a member? Log in here
The Evolving COVID-19 Market: FDA Clears the Way for Asymptomatic Screening Products
...
Already a member? Log in here
COVID-19 Surge Lifts Overall Molecular Point of Care Testing Market to $900 Million
...
Already a member? Log in here
FDA to SARS-CoV-2 Test Developers: Evaluate Impact of Genetic Mutations on Test Performance
...
Already a member? Log in here